Skip to main content
Log in

Epidemiological study of patients with systemic sclerosis in Tokyo

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

We conducted an epidemiological study of systemic sclerosis in the city of Tokyo using the records of patients who had been registered to receive free medical service for intractable diseases. A total of 636 patients were registered as having systemic sclerosis in 1987, and we sent questionnaires to the doctor of each patient. The contents of the questionnaires included the patient's name, sex, age, occupation, major symptoms, therapy and laboratory findings. We received 357 completed replies, and were able to analyse them. Our study estimated that at 1 January 1988 the prevalence rate in Japan was between 2.1 and 5.3 per 100000. The male/female ratio was 14:1. The ages of the patients when surveyed ranged from 17 to 82 years, with a mean age of 51 years, peaking with the most numerous group being 50–59 years. The characteristic signs of systemic sclerosis were as follows: proximal scleroderma, 75%; sclerodactyly, 91%; pitting scars, 49%; short sublingual frenulum, 49%; pulmonary fibrosis, 45%; diffuse pigmentation, 45%; and phalangeal contracture, 35%. Raynaud's phenomenon was present in 93% of patients, and was the initial symptom in 59% of cases. With respect to specific antinuclear antibodies, anticentromere antibody was present in 19% and antitopoisomerase I antibody was present in 27%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Rheumatism Association (1980) Subcommittee for Scleroderma Criteria, Diagnostic and Therapeutic Criteria committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Google Scholar 

  2. Asboe-Hansen G (1985) Epidemiology of progressive systemic sclerosis in Denmark. In: Black CM, Myers AR (eds) Systemic sclerosis (Scleroderma). Gower, New York, p 78

    Google Scholar 

  3. Barnett AJ (1974) In: Kugelmass IN (ed) Scleroderma, progressive systemic sclerosis. Thomas, Springfield, Ill., pp. 71–93

    Google Scholar 

  4. Barnett AJ (1985) Epidemiology of systemic sclerosis (Scleroderma) in Australia. In: Black CM, Myers AR (eds) Systemic sclerosis (Scleroderma). Gower, New York, pp. 82–83

    Google Scholar 

  5. de Kasep GI, Alarcon-Segovia D (1985) Preliminary epidemiologic data on progressive systemic sclerosis in Mexico. In: Black CM, Myers AR (eds) Systemic sclerosis (Scleroderma). Gower, New York, pp 70–71

    Google Scholar 

  6. Eason RJ, Tan PL, Gow PJ (1981) Progressive systemic sclerosis in Auckland: A ten-year review with emphasis on prognostic features. Aust N Z J Med 11:657–662

    Google Scholar 

  7. Giordano M, Valentini G, Ara M, Tirri G, Capelli L, Vatti M (1985) Epidemiology of progressive systemic sclerosis in Italy. In: Black CM, Myers AR (eds) Systemic sclerosis (Scleroderma). Gower, New York, pp. 72–77

    Google Scholar 

  8. Hatano H (1982) Epidemiology of connective tissue diseases of the skin (scleroderma, dermatomyositis, and polymyositis) in Japan. Hautarzt 33:355–358

    Google Scholar 

  9. Kurland LT, Hauser WA, Ferguson RH, Holley KE (1969) Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 44:649–663

    Google Scholar 

  10. McNeilage LJ, Youngchaiyud U, Whittingham S (1989) Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 32:54–60

    Google Scholar 

  11. Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI, LeRoy EC, McGregor AR, Diat F, Rosal EJ (1989) Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32:998–1005

    Google Scholar 

  12. Masi AT, D'Angelo WA (1967) Epidemiology of fatal systemic sclerosis. Ann Intern Med 66:870–883

    Google Scholar 

  13. Medsger TA Jr (1971) Epidemiology of systemic sclerosis. Ann Intern Med 74:714–721

    Google Scholar 

  14. Medsger TA Jr (1978) The epidemiology of systemic sclerosis among male US veterans. J Chronic Dis 31:73–85

    Google Scholar 

  15. Medsger TA Jr (1985) Epidemiology of progressive systemic sclerosis. In: Black CM, Myers AR (eds) Systemic sclerosis (Scleroderma). Gower, New York, pp. 53–60

    Google Scholar 

  16. Michet CJ, McKenna CH, Elveback LR, Kaslow RA, Kurland LT (1985) Epidemiology of systemic lupus erythematosus and other connective tissue disease in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 60:105–113

    Google Scholar 

  17. Shinkai H (1985) Epidemiology of progressive systemic sclerosis in Japan. In: Black CM, Myers AR (eds) Systemic sclerosis (Scleroderma). Gower, New York, pp. 79–81

    Google Scholar 

  18. Silman A, Jannini S, Symmons D, Bacon P (1988) An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 27:286–290

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamaki, T., Mori, S. & Takehara, K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 283, 366–371 (1991). https://doi.org/10.1007/BF00371817

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00371817

Key words

Navigation